Viewing Study NCT05721950


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-01-27 @ 2:12 AM
Study NCT ID: NCT05721950
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-27
First Post: 2023-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer (NSCLC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug Therapy View
None Real-world Data View
None Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors View